One patient was molecularly confirmed to have multiple endocrine neoplasia type 2 due to a pathogenic variant in the RET gene, which allowed for cascade screening in her sibling who also carried the variant. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.